develop serum hepatitis later in pregnancy or in the puerperium approaches 50 %. SINCE Stokes et al. (1954) , transmitted serum hepatitis to volunteers by injecting sera from a carrier mother and her infant with neonatal hepatitis, it has been assumed that this infection can cross the placenta to cause congenital liver disease. The availability of tests for Australia antigen, which is a good marker of the viraemic phase of serum hepatitis, now makes it possible to estimate the importance of this cause of neonatal hepatitis. This paper presents the findings in patients followed at the Virus Reference Laboratory, and reviews the results of similar studies in other countries.
Countercurrent electrophoresis was used for routine screening tests, and complement fixation tests and electronmicroscopy were used as needed. Radioimmunoassay was performed with 'Ausria' kits (Abbott) .
Hepatitis in pregnancy is rather uncommon. In 1968 Sever and White estimated its frequency as about 1/10,000 pregnancies in the United States. In London during 1969 and 1970 only nineteen cases were tested at the Virus Reference Laboratory and of these five were Australia antigen positive. In the first half of 1973 six mothers were tested because of 'hepatitis' in the last trimester of pregnancy. None were positive and all the cord bloods were negative. The babies were all healthy. In the same period four asymptomatic mothers were tested because their infants had neonatal hepatitis. The sera from all four mothers and infants were Australia antigen negative even by radioimmunoassay. One of these mothers had another affected child. by radioimmunoassay, and concentrates of colostrum from Cases 1 and 2 were negative by electronmicroscopy. An incidental point is that most of these mothers fell into the 'hippie hepatitis' group and that two had probably acquired the infection from their husbands. Table 2 shows the findings in three instances of pregnancy in Australia antigen carriers. The mothers were all tested at their first antenatal visit. By term, two had become antigen negative by electrophoresis, but one of these was again strongly antigen positive 3 months later. None of the babies was affected. Papaevangelou (1973) . but in at least one of these (positive by radioimmunoassay only) the baby escaped infection (Schweitzer et al., 1972) . Table 4 has been compiled to show the source of infection in the twenty-eight babies with Australia antigen positive hepatitis so far reported. More than 80% were born to mothers who had acute antigen positive hepatitis late in pregnancy or in the puerperium, and for more than half the onset of illness coincided with delivery and had presumably induced labour. It was not possible to assess the incubation periods from the information given but in all the cases where serial testing of the infant was possible antigenaemia developed between the second and twelfth weeks of life. The two infants whose hepatitis resulted from transfusion were also antigen positive by this age. The onset of abnormalities in liver function tests followed after variable intervals, but in almost all cases antigenaemia persisted indefinitely. This is probably because of the limited immune competence of infants. The outlook for these babies is uncertain and one at least has progressed to cirrhosis (Wright, Perkins and Bouch, 1970) while another has recovered and become antigen negative (Keys et al., 1972) .
Although hepatitis in pregnancy is rare, the Australia antigen carrier state is common, but seems to be of little importance for the infant. Aziz et al., 1973) Infant Au+ by 6 months age 2/6 (U.S.A. Schweitzer et al. 1972 ) 0/36 (Denmark, Skinhoj et al., 1972) 1/2 (Pakistan, Aziz et al., 1973) 0/14 (Pakistan, Aziz et al., 1973) 2/11 (Greece, Papaevangelou, 1973) It is not clear why there should be such a great difference in infectivity for the foetus between hepatitis and antigen carriage in pregnancy. From the circumstantial evidence of the antigen negative cord bloods it seems that infection is acquired during delivery rather than in utero. There is undoubtedly a great likelihood that the baby will swallow some blood stained liquor during even the last traumatic delivery, and in any case there is probably sufficient maternal blood leaked across the placenta during delivery to constitute exposure. However, the blood of hepatitis patients and carriers seems about equally infectious when injected into adults, so perhaps the placenta permits the passage of protective antibody (? anti-core) from the carriers to their offspring.
It is impossible to prevent exposure of infants to their mothers' blood but as congenital infection seems seldom to be manifest at delivery it High titre antibody to hepatitis B antigen was also given to the infant of an asymptomatic carrier because her three other children were hepatitis B antigen positive and had raised serum transaminases. At 6 months of age this infant remains free from antigen. Clearly, further follow-up of these cases and controlled trials will be necessary.
